Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

51.53 +0.02 (+0.04%)
Official Closing Price Updated: 7:00 PM EDT, Aug 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
45 46 Next >
News headline image
3 Gene Testing Stocks to Buy Before They Take Off ↗
The future of gene testing is bright thanks to an aging population. Here are three companies leading the industry. 
Via InvestorPlace
News headline image
UK Gives Nod To Roomba Maker IRobot-Amazon Deal, Micron Plans To Invest In China Despite Restrictions, Baidu Secures Regulatory Nod for Self-Driving Taxi: Today's Top Stories ↗
Benzinga 
Via Benzinga
News headline image
2 Top Healthcare Stocks to Buy Right Now ↗
The demand for healthcare sector goods and services is both predictable and growing. 
Via The Motley Fool
News headline image
Coherus BioSciences Acquires Small Immuno-Oncology Player Surface Oncology For $40M ↗
Coherus BioSciences Inc (NASDAQ: CHRS) has agreed to acquire Surface Oncology Inc (NASDAQ: SURF), a clinical-stage immuno-oncology (I-O) company developing next-generation immunotherapies that  
Via Benzinga
News headline image
FDA Pushes Review Time For GSK's Blood Cancer Therapy Added Via Sierra Oncology Acquisition ↗
The FDA has extended the review period for GSK plc's (NYSE: 
Via Benzinga
News headline image
Peering Into GSK's Recent Short Interest ↗
 
Via Benzinga
New Drugs in Fight Against Cancer Being Powered by Novel Mechanisms of Action
FN Media Group Presents USA News Group News Commentary Vancouver, BC – June 8, 2023 – USA News Group – By utilizing newly developed novel mechanisms, biotech researchers and scientists are making... 
Via FinancialNewsMedia
News headline image
ChatGPT's Parent Has No IPO Plans, CNN CEO Chris Licht Out, Kim Kardashian's Bid To Dismiss EthereumMax Lawsuit Rejected: Today's Top Stories ↗
Benzinga Cable Giant CNN Chairman, CEO Chris Licht Moves Out 
Via Benzinga
News headline image
GSK's Arexvy Gets the Green Light in Europe: First-Ever RSV Vaccine in Europe for Older Adults ↗
The European Commission has approved GSK plc's (NYSE:  
Via Benzinga
News headline image
June 2023 Stock Considerations ↗
With a new trading month already in full swing it is time, once again, to highlight some of my potential stock purchases. 
Via Talk Markets
News headline image
SEC Accuses Binance & Coinbase Of Acting As Unregistered Broker, Binance Takes Biggest Hit As $300M In Crypto Positions Liquidated In 24 Hours, JPMorgan Clarifies CEO Jamie Dimon Not Running For Presidency: Today's Top Stories ↗
Benzinga 
Via Benzinga
News headline image
FDA Prioritizes GSK's Breakthrough Drug Jemperli for Endometrial Cancer Treatment, a First in Decades ↗
 
Via Benzinga
News headline image
GSK Announces the COiMMUNITY Initiative to Help Achieve Higher Adult Vaccination Rates in the US
From GSK plc
Via Business Wire
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
WHO Recommends New COVID Booster Shots To Target XBB Variants, Despite Slower Uptake ↗
An advisory group for the World Health Organization said the current crop of shots should be updated to target the currently dominant XBB strains for the 
Via Benzinga
News headline image
BELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition
From BELLUS Health Inc.
Via Business Wire
News headline image
Could Latecomer Moderna Match Big Pharma Rivals in RSV? ↗
RSV is a key part of Moderna's respiratory vaccine business. 
Via The Motley Fool
News headline image
A Bitter Pill to Swallow: Teva's $235M Challenge to GSK Dismissed by Supreme Court ↗
The U.S. 
Via Benzinga
News headline image
3 Personalized Medicine Stocks to Buy for Long-Time Returns ↗
Personalized medicine is the future of medicine. Here are three personalized medicine stocks to invest in so you don't miss out. 
Via InvestorPlace
News headline image
GSK's Meningitis Vaccine Candidate: Crushing Clinical Trials or Just Playing Catch-up with Bexsero and Menveo? ↗
GSK plc (NYSE: GSK) presented preliminary results from the phase 3 trial of imm 
Via Benzinga
News headline image
Sanofi, AstraZeneca Release Real-World Data For Respiratory Syncytial Virus Antibody ↗
The race to tap the respiratory syncytial virus (RSV) this season intensifies as Sanofi SA (NASDAQ: SNY) and AstraZeneca Plc (NASDAQ: AZN) have  
Via Benzinga
News headline image
GSK Trims Stake On Consumer Business Spin Off, Raises £804M ↗
GSK Plc (NYSE: GSK) sold 240 mi 
Via Benzinga
News headline image
Sanofi Says Its RSV Shot Significantly Cut Hospitalization Risk In Newborns ↗
The monoclonal antibody shot significantly reduced the risk of hospitalization in babies. 
Via Investor's Business Daily
News headline image
SpringWorks Therapeutics Announces Clinical Data Presentations of Nirogacestat in Combination with BCMA-Directed Therapies at the European Hematology Association 2023 Congress
From SpringWorks Therapeutics, Inc.
Via GlobeNewswire
News headline image
The FDA Just Approved an RSV Vaccine -- and It Isn't From Moderna or Pfizer ↗
RSV could be the next big battleground for big pharma -- but it could soon become crowded. 
Via The Motley Fool
News headline image
Dividend Income Update April 2023 ↗
With May already underway it is time for all dividend income investors to look back at the previous month and see how much passive dividend income their portfolios generated. 
Via Talk Markets
News headline image
ImmunoGen Nearly Triples on Ovarian Cancer Drug Phase 3 Results
Commercial-state biotechnology company ImmunoGen Inc. (NASDAQ: IMGN) shares more than doubled on phase 3 clinical trial results. Its ovarian cancer drug 
Via MarketBeat
News headline image
WHO Ends Global Emergency Status for COVID-19 3 Years After Declaration, CDC Director Resigns ↗
The World Health Organization ended the global emergency 
Via Benzinga
News headline image
GSK: Add This Cheap Chip Play To Your Portfolio ↗
GSK pays a decent quarterly dividend. The latest declared dividend is $0.35 per share, giving GSK a yield of 3.85%. 
Via Talk Markets
News headline image
International Healthcare Week returns to showcase Hong Kong's strengths in healthcare innovation and investment
From HKTDC
Via ACN Newswire
< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
45 46 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.